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Introduction
Maintaining a stable genome is critical for the development and 
well-being of all organisms. Failure to maintain genome stability 
is associated with a large variety of diseases, including not only 
sporadic and inherited cancers but also several neurological, neuro-
degenerative, neuromuscular, and aging disorders (Hanahan 
and Weinberg, 2000; Hasty et al., 2003; Pearson et al., 2005).   
Although genomic instability is well known to be associated with 
different diseases, our knowledge about the pathways that pro-
tect the organism against genomic instability remains incom-
plete. However, studies in the model organism Saccharomyces 
cerevisiae have begun to provide a comprehensive description 
of the pathways and mechanisms that prevent genome instabil-
ity (for review see Kolodner et al., 2002). These include mecha-
nisms that protect against reactive oxygen species (Huang and 
Kolodner, 2005), promote fidelity of DNA replication (Chen 
and Kolodner, 1999), function in the S-phase checkpoint response 
(Myung et al., 2001c; Myung and Kolodner, 2002), control telo-
mere formation and maintenance (Pennaneach and Kolodner, 
2004), and assemble newly replicated DNA into chromatin 
(Myung et al., 2003). In addition, the activity of Cdk1 is crucial to 
maintain a stable genome (Kitazono and Kron, 2002; Lengronne 
and Schwob, 2002; Tanaka and Diffley, 2002; Kitazono et al., 
2003; Gibson et al., 2004).
Cdks govern cell cycle progression in eukaryotes. During 
each phase of the cell cycle, Cdks form a complex with specific 
cyclins that activate Cdks and help target them to their substrates 
(Bloom and Cross, 2007). A single Cdk, Cdc28, is sufficient for 
cell cycle progression in S. cerevisiae. Cdc28 controls a plethora 
of cell cycle–related processes, including specific transcriptional 
programs associated with each phase of the cell cycle, budding 
and cell morphogenesis, DNA replication, spindle pole body   
duplication, and mitotic spindle assembly (Kellogg, 2003; Bloom 
and Cross, 2007). Cdc28 is also involved in maintenance of telo-
meres, (Grandin and Charbonneau, 2003; Frank et al., 2006; 
Vodenicharov  and Wellinger,  2006),  contributing  to  telomere 
elongation by directly phosphorylating Cdc13 (Li et al., 2009).
W
e studied the function of the cyclin-dependent 
kinase Cdc28 (Cdk1) in the DNA damage 
response and maintenance of genome sta-
bility using Saccharomyces cerevisiae. Reduced Cdc28 
activity  sensitizes  cells  to  chronic  DNA  damage,  but 
Cdc28 is not required for cell viability upon acute expo-
sure to DNA-damaging agents. Cdc28 is also not re-
quired for activation of the DNA damage and replication 
checkpoints.  Chemical–genetic  analysis  reveals  that 
CDC28 functions in an extensive network of pathways 
involved in maintenance of genome stability, including 
homologous recombination, sister chromatid cohesion, 
the spindle checkpoint, postreplication repair, and telo-
mere  maintenance.  In  addition,  Cdc28  and  Mre11   
appear to cooperate to prevent mitotic catastrophe after 
DNA replication arrest. We show that reduced Cdc28 
activity results in suppression of gross chromosomal re-
arrangements (GCRs), indicating that Cdc28 is required 
for formation or recovery of GCRs. Thus, we conclude 
that Cdc28 functions in a genetic network that supports 
cell viability during DNA damage while promoting the 
formation of GCRs.
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this process was recently identified as the nuclease Sae2, which 
is directly phosphorylated and activated by Cdc28 (Huertas et al., 
2008). Efficient resection of a DSB may also involve additional 
factors such as the Mre11–Rad50–Xrs2 complex, the nucleases 
Dna2 and Exo1, and the helicase Sgs1 (Gravel et al., 2008; 
Mimitou and Symington, 2008; Zhu et al., 2008). The exposed 
single-stranded DNA (ssDNA) is subsequently bound by the 
replication protein A (RPA) complex, which is later replaced by 
Rad51. Rad52 then stimulates Rad51 to search for homologous 
sequences and is also involved in annealing the complementary 
ssDNA strands (Symington, 2002).
In this study, we analyzed the function of Cdc28 in the 
DNA damage response in more detail. We found that Cdc28 sup-
ports cell viability under conditions of chronic DNA damage, 
but it is not required for survival of acute genotoxic stress, and it 
does not appear to function as a direct regulator of the DNA 
damage and replication checkpoints. Furthermore, Cdc28 is part 
of an extensive genetic network of pathways involved in the 
maintenance of genome stability, and it cooperates with HR to 
prevent catastrophic mitotic progression after DNA replication 
arrest. Surprisingly, we found that Cdc28 activity is also required 
for formation of gross chromosomal rearrangements (GCRs). 
Therefore, Cdc28 maintains cell viability during DNA damage 
while contributing to the formation of genome rearrangements.
Results
Cdc28 promotes cell viability during 
chronic but not acute DNA damage and is 
not required for checkpoint activation
To test whether Cdc28 has a function in the response to DNA 
damage, we made use of two cdc28 mutants, cdc28-as1 (Bishop 
et al., 2000) and cdc28-5M (Li and Cai, 1997). The cdc28-as1 
allele encodes a kinase with an enlarged ATP-binding pocket,   
allowing it to bind the nonhydrolyzable ATP analogue 1-NM-PP1, 
and treatment of cells with 1-NM-PP1 results in rapid and highly 
specific down-regulation of Cdc28 kinase activity (Bishop et al., 
2000). However, it should be noted that cdc28-as1 is a hypo-
morphic allele because the kinase activity of this mutant is 
reduced by 20%, even in the absence of 1-NM-PP1 (Bishop 
et al., 2000). cdc28-5M encodes a temperature-sensitive form of 
Cdc28 with reduced kinase activity at the permissive tempera-
ture and further reduced kinase activity leading to lethality at 
elevated temperatures (Li and Cai, 1997). We spotted wild-type 
(WT) cells, cdc28-as1 mutants, and cdc28-5M mutants on yeast 
extract/peptone/dextrose (YPD) plates containing increasing but 
sublethal concentrations of 1-NM-PP1 in the absence or pres-
ence of various DNA-damaging agents. As expected, WT cells 
and cdc28-5M mutants were not affected by 1-NM-PP1, whereas 
the growth of cdc28-as1 mutants was slightly reduced at 60 and 
120 nM 1-NM-PP1 (Fig. 1). However, these sublethal concen-
trations of 1-NM-PP1 greatly sensitized cdc28-as1 mutants to 
DNA-damaging agents like camptothecin (CPT; which inhibits 
DNA topoisomerase I), methylmethanesulfonate (MMS; an   
alkylating agent), hydroxyurea (HU; which depletes deoxynucle-
oside triphosphates, resulting in DNA replication arrest), and UV 
irradiation (Fig. 1 and Fig. S1 A). Furthermore, cdc28-as1 mutants 
Cdk activity is tightly regulated; several mechanisms, often 
referred to as checkpoints (Hartwell and Weinert, 1989), have 
evolved that target Cdk activity to control the cell cycle in 
response to environmental and endogenous stresses that might 
compromise cell viability. For example, cells arrest the cell cycle 
in response to DNA damage and replication stress (Paulovich   
et al., 1997; Santocanale and Diffley, 1998). The DNA damage 
and replication checkpoints are defined as the pathways that 
promote cell cycle delay or arrest in response to DNA damage 
or DNA replication stress (Hartwell and Weinert, 1989). In ad-
dition, the DNA damage response also involves processes such as 
recruitment of DNA repair factors (Lisby et al., 2004), stabiliza-
tion of replication forks (Lopes et al., 2001), inhibition of late-
firing origins of replication (Santocanale and Diffley, 1998), and 
cytoplasmic events, including cell morphogenesis (Enserink et al., 
2006; Smolka et al., 2006) and nuclear positioning (Dotiwala   
et al., 2007). DNA replication stress and DNA damage induce 
activation of two phosphoinositide 3 kinase–related kinases,   
Tel1 and Mec1, which are similar to mammalian ataxia telangi-
ectasia  mutated  (ATM)  and ATM  and  Rad3  related  (ATR). 
These function in the activation of downstream protein kinases, 
including Chk1 and Rad53 (S. cerevisiae Chk2). In Schizosac-
charomyces pombe and higher eukaryotes, the DNA damage 
and DNA replication checkpoints inhibit Cdk activity to block 
cell cycle progression. In contrast, S. cerevisiae cells arrest with 
high Cdc28 activity upon genotoxic stress, and inhibition of 
Cdc28 activity is not essential for cell cycle arrest (Sorger and 
Murray, 1992). Instead, upon DNA damage or replication stress, 
S. cerevisiae cells directly target key processes involved in cell 
cycle progression, including inhibiting the firing of late replica-
tion  origins  and  blocking  mitosis  by  preventing  precocious 
chromosome segregation through inhibition of Cin8 and Stu2 as 
well as by stabilizing Pds1 (Yamamoto et al., 1996a,b; Cohen-
Fix and Koshland, 1997, 1999; Santocanale and Diffley, 1998; 
Sanchez et al., 1999; Krishnan et al., 2004).
The fact that S. cerevisiae cells arrest with high Cdc28 
activity allows for a function of Cdc28 in the DNA damage   
response. Indeed, several studies found that Cdc28 has functions 
in the DNA damage checkpoint activation and response, which 
may involve direct phosphorylation of Rad9 and Srs2 (Li and 
Cai, 1997; Liberi et al., 2000; Ira et al., 2004; Barlow et al., 
2008; Bonilla et al., 2008). Furthermore, Cdc28 is important for 
homologous recombination (HR) during mitosis as well as meio-
sis (Aylon et al., 2004; Ira et al., 2004; Henderson et al., 2006). 
DNA double-strand breaks (DSBs) can be repaired through HR 
or through nonhomologous end joining (NHEJ), and the choice 
of either of these pathways depends on the cell cycle: during G1 
phase, haploid yeast cells repair DSBs through NHEJ because 
of the absence of a template for HR, whereas in S and G2/M 
phases, they preferentially make use of HR (Ira et al., 2004), using 
the sister chromatid as a template. Furthermore, although Cdc28 
is active during the S and G2/M phases of the cell cycle, it is   
inactive during G1 phase because of low cyclin concentrations 
and a high abundance of the Cdk inhibitor (CKI) Sic1, and 
Cdc28 activity determines the mode of DSB repair because its 
activity is required for resection of the DSB (Ira et al., 2004), 
which is the first step in HR. The molecular target of Cdc28 in 425 CDC28 AND MAINTENANCE OF GENOME STABILITY • Enserink et al.
cdc28-5M mutants (Fig. S1, B and C). In contrast, mutants lack-
ing the checkpoint protein Rad53 did not survive acute treatment 
with these agents (Fig. 2 A).
To more directly determine whether Cdc28 has an effect 
on checkpoint activation, we studied the formation of Ddc2 
foci. Ddc2 functions in the initiation of DNA damage check-
point activation by mediating the interaction between Mec1 and the 
proliferating cell nuclear antigen–like Rad17/Ddc1/Mec3 clamp 
(Majka et al., 2006). Recruitment of Ddc2 to sites of DNA dam-
age can be visualized by fluorescence microscopy, and formation 
of Ddc2-GFP foci is used as a quantitative measure for check-
point activation (Lisby et al., 2004). We arrested cells in G1 and 
released them into YPD for 30 min. We then added 1-NM-PP1 
for 5 min to inactivate Cdc28-as1 before treating cells with phleo-
mycin, HU, or MMS. As shown in Fig. 3 A, Cdc28 was not 
essential for the formation of Ddc2 foci, which is in accordance 
with previous findings (Barlow et al., 2008). However, although 
the frequency of Ddc2 focus formation was not affected by Cdc28 
activity, we did notice that the intensity of Ddc2 foci was lower 
in 1-NM-PP1–treated cdc28-as1 mutants (unpublished data). We 
also studied the effect of Cdc28 on the formation of spontaneous 
rather than drug-induced Ddc2 foci in an mre11 mutant, which 
accumulates spontaneous DNA damage, resulting in high levels 
of  genome  rearrangements  (Myung  et  al.,  2001a).  Although 
10% of WT cells and cdc28-as1 mutants had at least one Ddc2 
focus, nearly 80% of mre11 single mutants had Ddc2 foci 
(Fig. 3 B). mre11 cdc28-as1 double mutants were similar to 
mre11 single mutants, and inhibition of Cdc28-as1 activity by 
were extremely sensitive to phleomycin (which induces free 
radical–mediated DNA damage, leading to single-strand breaks 
and DSBs [Sleigh, 1976]), even in the absence of 1-NM-PP1, 
which is likely caused by the fact that Cdc28-as1 has 20% lower 
kinase activity than WT Cdc28 (Bishop et al., 2000). cdc28-5M 
mutants were also very sensitive to MMS, HU, CPT, phleomycin, 
and UV irradiation (Fig. 1 and Fig. S1 A). These results show 
that Cdc28 activity is important for cell viability upon chronic 
exposure to various forms of DNA damage.
Unlike other eukaryotes, S. cerevisiae cells arrest with high 
levels of Cdc28 activity after treatment with DNA-damaging 
agents (Amon et al., 1992). Because Cdc28 activity is required 
for cell survival in the presence of different types of DNA-
damaging agents, it is possible that Cdc28 functions as a check-
point protein, something which has been suggested previously 
(Li and Cai, 1997; Ira et al., 2004; Barlow et al., 2008; Bonilla 
et al., 2008). Characteristically, checkpoint mutants do not 
recover from acute exposure to DNA-damaging agents as they 
fail to arrest the cell cycle and fail to stabilize replication forks 
(Lopes et al., 2001). To test whether Cdc28 has a checkpoint 
function, we first arrested WT cells and cdc28-as1 mutants in 
G1 phase with  factor and released them into YPD for 30 min 
to allow cells to go past Start (which is Cdc28 dependent) and 
enter S phase (which was confirmed by FACS analysis; unpub-
lished data). We then added 1-NM-PP1 for 5 min before treating 
with either HU or MMS for 2 h. cdc28-as1 mutants were not 
more sensitive to killing by HU or MMS (Fig. 2 A) or phleo-
mycin (Fig. 2 B) than WT cells. Similar results were obtained with 
Figure 1.  Cdc28 functions in the DNA damage response. 10-fold dilutions of log-phase cultures were spotted on YPD supplemented with increasing con-
centrations of 1-NM-PP1 and fixed concentrations of 10 µg/ml CPT, 0.05% MMS, 100 mM HU, and 1 µg/ml phleomycin (Phleo) or irradiated with 
100 J/m
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We also used FACS to determine whether Cdc28 is involved 
in the arrest of the cell cycle in response to MMS-induced DNA 
replication damage. We synchronized WT cells, rad53 mutants 
and cdc28-5M mutants in G1 and released them in YPD supple-
mented with 0.05% MMS. As shown in Fig. 3 E, WT cells   
arrested the cell cycle in the presence of MMS, whereas rad53 
mutants, which are checkpoint defective, did not show slow pro-
gression through the cell cycle. cdc28-5M mutants, which are 
very sensitive to MMS even at the permissive temperature (Fig. 1), 
entered S phase somewhat later than WT cells after release from 
 factor but efficiently arrested the cell cycle, indicating that 
Cdc28 is not required for activation of the checkpoint.
Another reason why mutants with reduced Cdc28 activ-
ity might be sensitive to DNA damage is that they might not   
recover from checkpoint activation, which is similar to what has 
been described for mutants lacking the phosphatases Ptc2, Ptc3, 
and Pph3 that down-regulate the checkpoint by dephosphorylat-
ing Rad53 (Leroy et al., 2003; O’Neill et al., 2007). To test 
whether Cdc28 may have a function in recovery from DNA rep-
lication arrest, we arrested WT cells and cdc28-as1 mutants in 
S phase for 3 h with HU and released them into either YPD or 
YPD supplemented with 1-NM-PP1. As shown in Fig. 3 F, in 
WT cells, Rad53 was largely dephosphorylated 1 h after release 
from HU arrest and almost completely dephosphorylated 2 h 
after release, indicating down-regulation of the checkpoint. The 
degree of Rad53 dephosphorylation in cdc28-as1 mutants was 
identical to that of WT cells and was not impaired by 1-NM-PP1, 
indicating that Cdc28 is not required for turning off the check-
point. In addition, FACS analysis showed that both WT cells 
and cdc28-as1 mutants had completed DNA replication 1 h   
after release from HU arrest, and this also was not affected by 
1-NM-PP1 (unpublished data). Therefore, although Cdc28 is 
important for cell viability during chronic exposure to DNA 
damage, it is not important for cell survival after acute DNA 
damage, and, by itself, it does not appear to have a major role in 
either the activation or down-regulation of DNA damage or rep-
lication checkpoints.
Cdc28 functions with Mre11 in recovery 
from DNA replication arrest
Although Cdc28 by itself may not be required to recover from 
DNA replication arrest, it might cooperate with certain DNA 
repair pathways for recovery and resumption of the cell cycle. 
Indeed, we found that CDC28 genetically interacts with many 
pathways involved in the maintenance of genome stability,   
including HR (see next section). To explore the possibility that 
Cdc28 cooperates with HR in recovery from DNA replication 
arrest, we made use of FACS analysis to test the ability of WT 
cells,  cdc28-5M  and  mre11  single  mutants,  and  cdc28-5M 
mre11 double mutants to recover from S-phase arrest and to 
go through M phase by treating them with HU and releasing 
them into medium containing  factor. Mutants that do not 
recover from replication arrest should be unable to complete M 
phase or to exit from M phase. We made use of the cdc28-5M 
allele because Cdc28-5M has strongly reduced kinase activity 
even  at  permissive  temperatures  (Li  and  Cai,  1997)  while   
retaining sufficient kinase activity to allow cells to go through 
1-NM-PP1 did not change the frequency of focus formation,   
although a reduction in the intensity of the foci was observed (un-
published data). We also monitored phosphorylation of Rad53 
upon treatment with DNA-damaging agents in WT cells and in 
cdc28-as1 mutants. MMS-induced Rad53 activation was not 
inhibited by 1-NM-PP1 (Fig. 3 C), indicating that Cdc28 is not 
required for MMS-induced Rad53 activation, which is similar 
to the previously reported findings that 4-nitroquinoline 1-oxide–
induced Rad53 activation is independent of Cdc28 (Ira et al., 
2004) and that Cdc28 by itself is not essential for Rad53 acti-
vation (Barlow et al., 2008). Interestingly, we found that phleo-
mycin-induced Rad53 phosphorylation was partially reduced in 
1-NM-PP1–treated cdc28-as1 mutants, indicating that check-
point activation by phleomycin-induced DNA damage may be 
partially dependent on Cdc28 (Fig. 3 D).
Figure 2.  Cdc28 does not have a replication checkpoint function. (A) Cell 
survival after HU- or MMS-induced DNA damage does not depend on 
Cdc28 activity. WT cells or cdc28-as1 or rad53 mutants were treated with 
10 µM 1-NM-PP1, 200 mM HU, or 0.05% MMS for 2 h, washed, and 
plated on YPD as described in Materials and methods. Cell survival was 
calculated as a percentage of untreated WT cells. (B) Cell survival after 
phleomycin (Phleo)-induced DNA damage does not depend on Cdc28 
activity. WT cells or cdc28-as1 mutants were treated as in A with 1-NM-PP1 
and increasing concentrations of phleomycin, and the percentage of cell 
survival was determined. (A and B) Error bars represent standard devia-
tion. CFU, colony-forming unit.427 CDC28 AND MAINTENANCE OF GENOME STABILITY • Enserink et al.
Figure 3.  Cdc28 has no major role in DNA damage–induced checkpoint activation. (A) DNA damage–induced formation of Ddc2 foci is independent of 
Cdc28. Cells were arrested with  factor and released into YPD or YPD containing 10 µM 1-NM-PP1 and the indicated DNA-damaging agents for 2 or 4 h, 
as indicated (see Materials and methods). Ddc2-GFP foci were visualized using fluorescence microscopy, and the percentage of cells with foci relative to 
the total cell population of that specific sample was calculated. Phleo, phleomycin. (B) Checkpoint activation upon endogenous DNA damage does not 
depend on Cdc28 activity. WT cells and cdc28-as1, mre11, and cdc28-as1 mre11 mutants were arrested in  factor before being released into YPD 
supplemented with 10 µM 1-NM-PP1 for 2 h, and the percentage of cells with Ddc2-GFP foci were determined as described in A. Error bars represent stan-
dard deviation. (C) MMS-induced phosphorylation of Rad53 is independent of Cdc28. WT cells and cdc28-as1 mutants were arrested in  factor () and 
released into YPD for 30 min to allow cells to enter S phase. Then, either DMSO or 1-NM-PP1 was added to inactivate Cdc28-as1 (time point 0) followed 
by treatment with MMS for 30, 60, or 120 min. Cell lysates were analyzed by Western blotting using Flag antibodies to detect Rad53. (D) Phleomycin-
induced phosphorylation of Rad53 is partially dependent on Cdc28. WT cells and cdc28-as1 mutants were arrested in  factor and released into YPD 
for 30 min to allow cells to enter S phase. Then, either DMSO or 1-NM-PP1 was added to inactivate Cdc28-as1 (time point 0) followed by treatment with 
phleomycin for 60, 120, or 180 min. Cell lysates were analyzed by Western blotting using Flag antibodies to detect Rad53. (E) Cdc28 is not required for 
MMS-induced S-phase arrest. WT cells and cdc28-5M and rad53 mutants were grown into log phase (log) or arrested in  factor before being released 
into YPD supplemented with 0.05% MMS. Samples were taken at the indicated time points and analyzed by FACS. (F) Checkpoint inactivation after repli-
cation arrest does not require Cdc28 activity. WT cells and cdc28-as1 mutants were arrested in HU for 3 h before HU was washed away, and cells were 
resuspended in YPD supplemented with either DMSO or 10 µM 1-NM-PP1. Samples were taken at the indicated time intervals, and Rad53 phosphorylation 
was analyzed as in C. P-Rad53, phospho-Rad53.JCB • VOLUME 185 • NUMBER 3 • 2009   428
double mutant had a strong defect in recovering from DNA rep-
lication arrest, as the majority of cells were unable to progress 
through M phase (Fig. 4 D). In addition, those cells that did 
manage to exit from M phase appeared to have <1 N DNA con-
tent, as indicated by the absence of a distinct G1-phase peak and 
the presence of a large sub–G1 phase population instead. We 
also  made  use  of  pulsed-field  gel  electrophoresis  (PFGE)   
to monitor chromosomal integrity. We found that log-phase   
WT cells had very low levels of chromosome fragmentation, 
which increased after treatment with HU (Fig. 4 E and Fig. S2). 
mre11 mutants had levels of chromosome fragmentation that 
were comparable with that of WT cells. Interestingly, log-phase 
cdc28-5M mutants showed increased chromosome fragmenta-
tion (Fig. 4 E), although this was not further increased by HU 
treatment. Furthermore, mre11 cdc28-5M double mutants 
did not have higher levels of chromosome fragmentation than 
M phase (inhibition of Cdc28 activity using 1-NM-PP1 treatment 
of cdc28-as1 mutants results in complete M-phase arrest [Bishop 
et al., 2000] and, therefore, is not suitable for studying exit from 
M phase). As shown in Fig. 4 A, after 40 min, WT cells had   
recovered from HU arrest and completed bulk DNA synthesis. 
All cells had exited from M phase and accumulated in G1 phase 
after 180 min. The cdc28-5M single mutant also completed DNA 
synthesis after 40 min but exited from M phase slower than WT, 
accumulating in G1 phase after 180 min (Fig. 4 B). Interest-
ingly, a portion of cdc28-5M mutants accumulated with sub-G1 
DNA content, indicating a certain degree of mitotic catastrophe, 
which is consistent with a previous study implicating Cdc28 in 
prevention of mitotic catastrophe (Kitazono and Kron, 2002). 
mre11 mutants were delayed in passing through M phase 
(Fig. 4 C), although a relatively large number of cells ultimately 
accumulated in G1 phase. However, the mre11 cdc28-5M 
Figure 4.  Cdc28 cooperates with Mre11 to maintain genome sta-
bility. Cdc28 cooperates with Mre11 to prevent mitotic catastrophe 
after DNA replication arrest. (A–D) WT cells (A), cdc28-5M mutants 
(B), mre11 mutants (C), and mre11 cdc28-5M double mutants (D) 
were arrested in HU for 3 h before being released into YPD supple-
mented with  factor at 30°C. Samples were taken at the indicated 
time intervals and analyzed using FACS analysis. (E) Cdc28 prevents 
chromosome fragmentation. WT cells and mre11, cdc28-5M, and 
mre11 cdc28-5M mutants were treated as indicated, and whole 
chromosomes were analyzed by PFGE. The relative amount of chro-
mosome fragmentation (at 30°C because incubation at 37°C did 
not further increase fragmentation) was calculated as described in 
Materials and methods. Error bars represent the standard error of 
the mean.429 CDC28 AND MAINTENANCE OF GENOME STABILITY • Enserink et al.
the  600–fold  increase  that  has  been  published  previously 
(Lengronne and Schwob, 2002) but consistent with the 19-fold 
increase in GCR rates obtained with overexpression of CLN2-1, 
which encodes a stabilized form of Cln2 that also induces pre-
cocious entry into S phase by elevating the activity of Cdc28 
(Tanaka and Diffley, 2002). In addition, deletion of FAR1, a CKI 
that directly inhibits cyclin–Cdc28 complexes to prevent entry 
into S phase (Peter and Herskowitz, 1994), resulted in a similar 
increase in GCR rates (Table I), whereas simultaneous deletion 
of SIC1 and FAR1 appeared to result in an additive effect, lead-
ing to a 33-fold increase in GCR rates (Table I). Mutants lack-
ing Swe1, the budding yeast homologue of mammalian Wee1 
that directly phosphorylates and inhibits Cdc28 to inhibit entry 
into M phase when certain aspects of cytoskeletal function or 
bud formation are impaired (Lew, 2003), did not have increased 
cdc28-5M single mutants. Collectively, these results indicate 
that Cdc28 cooperates with Mre11 to prevent catastrophic 
M-phase progression after DNA replication stress.
Cdc28 is required for the formation  
of GCRs
To further characterize the effect of Cdc28 on the maintenance 
of genome stability, we analyzed its effect on GCR formation. 
First, we measured GCR rates in strains with increased Cdc28 
activity  generated  by  deleting  genes  encoding  endogenous   
inhibitors of Cdc28. Mutants lacking the CKI Sic1 (the func-
tional homologue of mammalian p27
KIP1 [Barberis et al., 2005]), 
which prevents precocious entry into S phase by inhibiting 
cyclin B–Cdc28 complexes (Schwob et al., 1994), had a 17-fold 
increase in GCR rate (Table I). This is significantly lower than 
Table I.  Mutations in CDC28 suppress GCR rates
Relevant genotype Mutation rate (Can
r  5FOA
r) (×10
10)
CDC28 cdc28-as1 cdc28-5M
WT 3.50 (1)
a <12.5 (<3.6)
b <128 (<37)
b
CKIs
sic1 59.5 (17) NT NT
far1 71.1 (20) NT NT
sic1 far1 115.9 (33) NT NT
swe1 <5.69 (<1.6)
b NT NT
HR
rad50 2,300 (657)
a 148 (42) NT
mre11 2,490 (711) 128 (37) <327 (93)
b
mre11 in nocodazole
g 5,700 (1,622) NT NT
mre11 in SC, RT
h 1,890 (543) NT NT
mre11 yku80 6,156 (1,759) 542 (155) NT
rad52 350 (100)
c 290 (83) <446 (127)
b
sae2 177 (51) <67 (<19)
b NT
sae2 mre11 2,798 (797) NT NT
DNA damage and  
replication checkpoint
mec1 680 (194)
d NT <33 (<9)
b
mec1 tel1  45,000 (12,857)
d NT 2,390 (683)
rad53 95 (27)
d <9.6 (<2.7)
b NT
pds1 670 (190)
d <64 (<18)
b NT
rfc5-1  660 (189)
d <5.1 (<1.5)
b NT
rad17 30 (9)
d <14 (<4)
b NT
rad24 40 (11)
d <26 (<7.4)
b NT
Others
sgs1 77 (22)
e 60 (17) <74 (<21)
b
rfa1-t11 (CEN) 420 (120)
a <69 (<20)
b NT
rad27 4,400 (1,257)
e NT <277 (<79)
b
tsa1 173 (49)
f NT <84 (24)
b
pif1 3,530 (1,008)
c 519 (148) 200 (57)
NT, not tested. Numbers in parentheses indicate fold increase over WT. The mutation rates are shown as events per generation.
aData from Chen and Kolodner (1999).
bGCR rates could not be accurately calculated because GCRs were not detected in a large enough proportion of the cultures.
cData from Myung et al. (2001a).
dData from Myung et al. (2001c).
eData from Myung et al. (2001b).
fData from Huang and Kolodner (2005).
gmre11 mutants were grown in 10 µM nocodazole until stationary phase to test the effect of delaying the cell cycle on GCR rates.
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futile  attempts  to  perform  HR  that  might  otherwise  lead  to 
GCRs. The DSBs might be channeled into the NHEJ pathway 
instead, resulting in an apparent reduction in GCR rates. If this 
model were correct, one would predict that depleting Sae2 would 
result in suppression of the GCR rates of mre11 mutants. Con-
versely, inactivation of the NHEJ pathway by deleting YKU80 
in an mre11 cdc28-as1 background should then restore GCR 
rates. However, we found that a sae2 single mutant had a GCR 
rate of 50-fold over WT, and a sae2 mre11 double mutant 
had a GCR rate of 797-fold over WT, which is identical to that 
of mre11 single mutants (Table I). Furthermore, the GCR rate 
of sae2 mutants was suppressed by the cdc28-as1 allele. 
Finally, yku80 mre11 cdc28-as1 triple mutants had a GCR 
rate of 155-fold over WT, compared with 1,759-fold for yku80 
mre11 double mutants (Table I). We conclude that channel-
ing of DSBs into the NHEJ pathway is not involved in cdc28-
mediated suppression of GCRs because (a) deletion of SAE2 
does not result in suppression of GCRs and therefore failure to 
fully activate Sae2 cannot explain the suppressive effect of 
cdc28 mutations on formation of GCRs, and (b) deletion of 
YKU80 does not restore the suppressed GCR rates of mre11 
cdc28-as1 mutants.
We also determined the effect of cdc28-as1 and cdc28-5M 
mutations on the GCR rates of cells with deletions in various 
DNA  damage  and  replication  checkpoint  genes,  including 
RAD17, RAD24, RAD53, MEC1, and a combination of MEC1 
and TEL1. In all cases, mutations in CDC28 suppressed the 
increased GCR rates (Table I), and in most cases, no GCR 
events could be detected in mutants in the cdc28-5M back-
ground. The one exception was the mec1 tel1 cdc28-5M 
triple mutant, which had a GCR rate that was increased 700-
fold over the WT rate; however, because mec1 tel1 double 
mutants have a GCR rate that is increased 12,000-fold over the 
WT rate, the cdc28-5M mutation was still a potent suppressor of 
GCRs. The cdc28-as1 and cdc28-5M mutations also suppressed 
GCR rates of rfa1-t11, rfc5-1, tsa1, pds1, asf1, sgs1, 
rad27, and tsa1 mutants and at least partially suppressed the 
increased GCR rate of a pif1 mutant, which acquires GCRs 
that are exclusively de novo telomere additions. In conclusion, 
these data show that mutations in CDC28 have a broad sup-
pressive effect on the increased accumulation of GCRs in many   
mutant  backgrounds,  indicating  a  general  requirement  for 
Cdc28 activity in formation of GCRs.
Cdc28 activity does not suppress the 
increased mutation rate caused by an 
msh2 mutation
To determine whether Cdc28 also affects the accumulation of 
mutations like base substitutions and frameshifts, we made use of 
three mutator assays: the CAN1 forward mutation assay, which 
scores for mutations that inactivate the CAN1 gene, the lys2-Bgl 
reversion assay, which detects reversion of a +4 insertion in the   
LYS2 gene, and the hom3-10 reversion assay, which detects   
reversion of a +1 insertion in the HOM3 gene. The lys2-Bgl and 
the hom3-10 assays are particularly sensitive for detecting 
defects in mismatch repair, whereas the CAN1 assay detects a 
broad range of mutator phenotypes (Marsischky et al., 1996; 
GCR rates (Table I). Therefore, consistent with previous find-
ings (Lengronne and Schwob, 2002; Tanaka and Diffley, 2002), 
unscheduled activation of Cdc28 during G1–S phase resulted 
in increased GCR rates, reiterating the belief that most GCRs 
stem from processes related to DNA replication (for review see 
Kolodner et al., 2002).
Because increased Cdc28 activity resulted in increased GCR 
rates, we next asked what the effect would be of reduced Cdc28 
activity on GCR rates. Typically, mutations in genes that are   
involved in the DNA damage response lead to increased GCR 
rates, presumably because damaged chromosomes are not faith-
fully repaired (for review see Kolodner et al., 2002). Therefore, 
because we found that Cdc28 is involved in the response to 
DNA damage (Fig. 1 and Fig. S1 A), we expected cdc28 mutants 
to have increased GCR rates. However, we did not observe a 
single GCR event in cultures of either cdc28-as1 or cdc28-5M 
mutants and, therefore, could only calculate an upper limit for 
the GCR rate of these strains (Table I); the actual rate is likely 
to be lower. We next tested whether cdc28 mutations can sup-
press the increased GCR rates caused by well-known mutator 
mutations such as mre11 and rad50 (Myung et al., 2001a). 
As shown in Table I, mre11 and rad50 single mutants have 
GCR rates that are 700-fold higher than WT. However, even 
in the absence of 1-NM-PP1, mre11 cdc28-as1 and rad50 
cdc28-as1 double mutants only had 40-fold increased GCR 
rates. Thus, a modest reduction in Cdc28 activity was sufficient 
to largely suppress GCR rates of mre11 and rad50 mutants. 
In addition, cultures of mre11 cdc28-5M double mutants 
did not form even a single GCR, and, therefore, accurate GCR 
rates could not be calculated for this strain. The increased GCR 
rate of mutants lacking Rad52 was also suppressed by cdc28 
mutations (Table I).
One  might  argue  that  the  suppressive  effect  of  cdc28  
mutations on GCR rates might be caused by the reduced speed 
with which the mutants traverse the cell cycle. We tested that 
possibility by artificially reducing growth rates by culturing mre11 
mutants at RT in synthetic complete media. These conditions 
substantially reduced growth rates of this mutant (unpublished 
data) but had basically no effect on the GCR rate, which was 
543-fold over WT (Table I). In addition, we cultured mre11  
mutants in YPD supplemented with a sublethal dose (10 µM) of 
nocodazole, which strongly reduced the growth rate of this mu-
tant, taking up to 5 d to reach stationary phase (unpublished 
data). However, this treatment resulted in increased rather than 
decreased GCR rates of mre11 mutants (1,622-fold over WT; 
Table I). Therefore, the suppression of GCR formation by hypo-
morphic cdc28 alleles is not a result of the reduced speed with 
which these mutants pass through the cell cycle. Alternatively, 
the suppressive effect of cdc28-as1 and cdc28-5M on formation 
of GCRs in mre11 mutants could also be a result of the   
reduced activity of the nuclease Sae2. Cdc28 has recently been 
shown to phosphorylate and thereby stimulate the activity of 
Sae2,  resulting  in  the  resection  of  DSBs  to  expose  ssDNA, 
which is the first step in HR (Huertas et al., 2008). One could 
argue that mutants harboring cdc28 alleles suppress the GCRs 
that arise in HR-defective mre11 mutants because Cdc28 is 
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indicates that these double mutants may have to go through sev-
eral rounds of the cell cycle under conditions of reduced Cdc28 
activity before losing cell viability, which could potentially be 
the result of chromosome loss events. Finally, using a bioinfor-
matics  approach  (see  Materials  and  methods),  we  identified   
additional genetic interactions between CDC28 and genes   
previously implicated in the maintenance of genome stability 
(Table S1; Pan et al., 2006). Although we did not confirm every 
predicted genetic interaction, we found that 14 out of 18 (78%) 
genes tested genetically interacted with CDC28. Therefore, our 
methodology for prediction of genetic interactions should be 
widely applicable. An overview of the CDC28 genetic network 
involved in maintenance of genome stability is shown in Fig. 5 C; 
CDC28 genetically interacts with a wide range of pathways in-
volved in genome stability, thus underscoring the importance of 
Cdc28 in this process.
Discussion
CDC28 is required for survival of chronic 
but not acute DNA damage
The role of Cdc28 in DNA damage–induced checkpoint acti-
vation is currently unclear. It has been shown that Cdc28 is   
required for checkpoint activation after induction of a homo-
thallic switching (HO) endonuclease break during the G2 phase 
but not the G1 phase of the cell cycle (Ira et al., 2004). Further-
more, artificial recruitment of Ddc1-lacI (which recruits the 
Ddc1–Mec1 complex) and Ddc2-lacI (which recruits the 9-1-1 
complex that consists of Ddc2, Mec3, and Rad17) chimaeras to 
a chromosomal array of lac operators has been shown to induce 
Rad53 phosphorylation even in the absence of DNA damage, 
and this was dependent on Cdc28-mediated phosphorylation of 
Rad9 (Bonilla et al., 2008). In another study, it was reported 
that Cdc28 was important for Ddc2 foci formation but, by   
itself, is not required for ionizing radiation–induced Rad53 
phosphorylation (Barlow et al., 2008); rather, Cdc28 had a   
redundant role with RPA in the activation of Rad53 (Barlow et al., 
2008). In this study, we have shown that Cdc28 functions in the 
maintenance of cell viability in the presence of various types of 
DNA damage, including HU-induced replication fork stalling, 
alkylation of DNA (MMS), cross-linked nucleotides (UV) and 
free radical–mediated DNA damage (phleomycin). However, 
Cdc28 by itself did not seem to have a major effect on either 
checkpoint activation or cell survival upon acute exposure to 
most of these types of DNA-damaging agents, indicating that 
Cdc28 is not a key regulator of checkpoint responses to most 
types of DNA damage. We only observed a partial effect of 
Greene and Jinks-Robertson, 1997; Tishkoff et al., 1997; Tran 
et al., 1997; Umezu et al., 1998). As shown in Table II, the 
cdc28-5M mutation did not affect mutation rates in any of these 
assays. Furthermore, the cdc28-5M mutation did not suppress 
the high mutation rates of mutants lacking the Msh2 mismatch 
repair protein. Therefore, it seems likely that Cdc28 might spe-
cifically affect the processing or the stability of broken chromo-
somes that underlie the formation of GCRs.
CDC28 is part of a genetic network that 
preserves chromosomal stability
We next wanted to gain insight into the genetic network that   
involves CDC28 and that promotes cell survival. We made use 
of a directed chemical–genetics approach to test for genetic inter-
actions between cdc28-as1 and defects in the major pathways 
involved in maintenance of genome stability. We spotted double 
mutants on either YPD plates supplemented with DMSO or 
YPD plates containing 200 nM 1-NM-PP1, which is a sublethal 
concentration that still permits growth of cdc28-as1 single   
mutants. We found that a variety of genetic pathways function 
with CDC28 to maintain cell viability (Table III and Fig. S3 A). 
For instance, CDC28 genetically interacted with genes involved 
in HR (MRE11, RAD50, RAD52, and POL32), sister chromatid 
cohesion (CTF4 and CTF18), the DNA replication and DNA 
damage checkpoints (RAD53 and a combination of MEC1 and 
TEL1), the spindle checkpoint and mitotic exit network (BUB3, 
MAD2, and BUB2), the RNA component of telomerase (TLC1), 
DNA replication (RFA1), flap endonuclease (RAD27), and chro-
matin remodeling (ASF1). CDC28 also showed strong genetic 
interactions with components of the postreplication repair path-
way, particularly RAD6, and also with RAD18 and RAD5. Dele-
tion  of  RAD6  resulted  in  synthetic  lethality  in  a  cdc28-5M 
background (Fig. 5 A), which was rescued by a plasmid harbor-
ing WT RAD6 (Fig. 5 B) but not by a plasmid encoding the cata-
lytically inactive Rad6-C88A mutant (not depicted) and was 
partially rescued by a plasmid harboring rad6-149, which 
encodes a mutant of Rad6 that lacks the acidic C terminus and 
which  is  particularly  deficient  in  ubiquitination  of  histones 
(Sung et al., 1988; Robzyk et al., 2000). We also found genetic 
interactions between CDC28 and BRE1 and LGE1, whose gene 
products function in complex with Rad6 in H2B ubiquitination 
(Hwang et al., 2003; Wood et al., 2003). All of the genetic inter-
actions with CDC28 that we observed in this study were seen 
under conditions of chronic but not acute inhibition of Cdc28; a 
brief treatment of each of the double mutants with 1-NM-PP1 
resulted in little or no loss of cell viability (Fig. S3 B). The fact 
that a brief inhibition of Cdc28 in these mutants is reversible 
Table II.  Reduced Cdc28 activity does not affect non-GCR mutation rates
Relevant genotype Hom
+ rate (×10
8) Lys
+ rate (×10
8) Can
r rate (×10
7)
WT 1.4 (1.2–1.5) 1.9 (1.4–2.7) 3.6 (3.1–5.2)
cdc28-5M 1.2 (0.8–1.6) 1.8 (1.6–2.5) 2.3 (1.9–5.8)
msh2 670.2 (405.9–832.8) 62.1 (50.8–99.0) 34.6 (16.6–48.8)
msh2 cdc28-5M 967.7 (505.4–1,730.9) 55.3 (45.1–73.6) 39.3 (31.4–67.6)
Numbers in parentheses indicate confidence intervals. The mutation rates are shown as events per generation.JCB • VOLUME 185 • NUMBER 3 • 2009   432
Table III.  Genetic interactions with CDC28
Relevant genotype Sensitivity to 200 nM 1-NM-PP1
  CDC28 cdc28-as1
WT  
Recombination
mre11  ++++
rad50  ++++
rad51  +
rad52  +++
rad54  
pol32  ++++
sae2  +
RPA complex
rfa1-t6  ++++
rfa1-t11  ++++
rfa1-t19  ++++
rfa1-t48  ++++
NHEJ
yku80  +
lig4  
Replication fork  
  progression
top3  +
sgs1  +
rrm3  
srs2  
mus81  
mus81 mms4  
slx1  +++
Nucleotide excision  
  repair
rad10  
Okazaki fragments
rnh201 rnh203  
rad27  ++++
Postreplication repair
rad5  ++
rad6  ++++
rad18  ++
pol30-119  +
DNA damage and  
replication checkpoints
rad17  
rad24  
rfc5-1  +
elg1  +
tof1  +
csm3  ++
mec1  
tel1  
mec1 tel1  ++
rad53  ++
chk1  
Spindle checkpoint/  
  mitotic exit
bub3  ++++
mad2  +++
bub2  +++
Sister chromatid cohesion
ctf4  ++++
ctf18  ++++
Cdc28 on Rad53 phosphorylation after phleomycin treatment, 
which  is  thought  to  induce  DSBs  (Sleigh,  1976).  Because 
phleomycin-induced formation of Ddc2-GFP foci in cdc28-as1 
mutants was not affected by 1-NM-PP1, Cdc28 appears to have 
a function downstream of Ddc2 but upstream of Rad53, which 
is in accordance with a previous study showing that Cdc28 
might be important for Rad9 activity (Bonilla et al., 2008). 
Apart from this, our finding that Cdc28 by itself was not a major 
player in checkpoint activation seems at variance with previous 
studies that implicate Cdc28 in checkpoint activation (Ira et al., 
2004; Barlow et al., 2008; Bonilla et al., 2008). One explana-
tion might be that Cdc28 is involved in DNA damage check-
point activation by DSBs that are induced by HO breaks (Ira 
et al., 2004),  irradiation (Barlow et al., 2008), and, to a cer-
tain extent, by phleomycin (this study), but Cdc28 might not be 
required for checkpoint activation after DNA-damaging treat-
ments that mainly result in replication fork stalling such as 
MMS and HU. Furthermore, the effect of Cdc28 on DNA dam-
age checkpoint activation has thus far mainly been studied in 
cells that were arrested in either G1 phase or in G2/M phase (Li 
and Cai, 1997; Ira et al., 2004; Barlow et al., 2008; Bonilla et al., 
2008),  whereas  we  studied  the  effect  of  DNA  damage  in   
S phase. It was recently shown that DNA damage during S phase 
results in much more potent checkpoint activation than during 
either G1 phase or G2/M phase as a result of replication fork 
stalling (Zierhut and Diffley, 2008). Because we used the repli-
cation fork stalling agents MMS and HU, it is possible that 
checkpoint activation by stalled replication forks may either 
not require Cdc28 or it might result in such a strong signal that 
the requirement for Cdc28 is overridden.
Although  Cdc28  activity  alone  did  not  appear  to  be   
involved in recovery from replication checkpoint arrest, we found 
that it cooperates with Mre11 to prevent mitotic catastrophe 
after replication arrest. Cdc28 has previously been shown to be 
required for the resection step of HR (Aylon et al., 2004; Ira 
et al., 2004; Henderson et al., 2006), but our finding that CDC28 
is not epistatic to MRE11 and RAD52 (Tables I and III) indi-
cates that Cdc28 likely has additional functions as well. We cur-
rently do not know the nature of this function, but based on the 
results of our GCR assays (see next section), we speculate that 
Cdc28 may somehow help prevent loss of damaged chromo-
somes, as has been suggested previously (Kitazono and Kron, 
2002; Kitazono et al., 2003).
Cdc28 activity is required for formation  
of GCRs
We evaluated the function of CDC28 in formation of GCRs 
and found that Cdc28 activity directly correlated with the rate 
of GCR formation; augmented Cdc28 activity led to elevated 
GCR rates, whereas a reduction in Cdc28 activity resulted in 
suppression of GCRs. Reduced Cdc28 activity did not affect 
the rate of accumulation of mutations in the CAN1, hom3-10, 
or lys2-Bgl assays and did not suppress the mutator phenotype 
caused by an msh2 mutation, indicating that Cdc28 specif-
ically affects the formation of GCRs. Mutations that cause defects   
in mitotic checkpoint functions were previously shown to sup-
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with HU, and (c) mre11 cdc28-5M and rad27 cdc28-5M 
double mutants had defects in maintenance of minichromo-
somes (unpublished data), indicating that chromosomes might 
indeed be lost after being damaged in these mutants.
There may be additional explanations for suppression of 
GCRs by cdc28 alleles. For example, initiation of DNA repli-
cation is controlled by Cdc28 (Diffley, 2004), and deletion of 
CDC28  or  overexpression  of  CLN2-1  induces  unscheduled   
entry into S phase, resulting in increased GCR rates (Lengronne 
and  Schwob,  2002;  Tanaka  and  Diffley,  2002).  Introducing 
seven extra copies of the autonomously replicating sequence 
ARSH4 between CAN1 and URA3 suppressed the GCR rates 
induced by CLN2-1 overexpression, and, therefore, GCRs that 
arise by precocious S-phase entry could be a result of poor   
assembly of prereplicative complexes (Tanaka and Diffley, 2002). 
Therefore,  we  hypothesized  that  suppression  of  GCRs  by   
hypomorphic cdc28 alleles might be a result of delayed entry 
into S phase, allowing cells to more efficiently assemble pre-
replicative complexes. Interestingly, we found that the introduc-
tion of extra copies of ARSH4 into a WT strain did not reduce 
GCR rates (Table IV) but, in fact, resulted in a fourfold in-
crease in the GCR rate. Extra copies of ARSH4 also increased 
the GCR rate of mre11 mutants by about fourfold (Table IV). 
Therefore, suppression of GCR rates by hypomorphic cdc28 
alleles does not appear to be the result of improved assembly of 
prereplicative complexes. An alternative explanation for sup-
pression of GCRs in strains with hypomorphic cdc28 alleles 
could be that these mutants fire their origins of replication less 
efficiently, resulting in a lower total number of replication forks 
and therefore a smaller chance of replication fork collapse and 
thus less damage that could lead to GCRs. However, this is not 
likely to be the mechanism of GCR suppression because, in 
that case, one would expect to see fewer Ddc2 foci during   
S phase in mutants with hypomorphic cdc28 alleles, but this is 
not  the  case  (Fig.  3, A  and  B).  Furthermore,  hypomorphic 
cdc28 alleles did not reduce the number of Ddc2 foci in mre11 
mutants during S phase, indicating that the amount of damage 
in these cells is not reduced, and, therefore, it is unlikely that 
suppression of GCR rates by cdc28 alleles is caused by a lower 
amount of DNA damage.
The CDC28 genetic network
We identified genetic interactions between CDC28 and genes 
involved in a plethora of pathways that function in DNA damage 
responses  and  in  the  maintenance  of  genome  stability. These   
include HR, sister chromatid cohesion, the spindle checkpoint, 
postreplication repair, telomere maintenance, and chromatin   
remodeling, underscoring the importance of Cdc28 in maintenance 
of genome stability. Given that Cdc28 controls a wide variety of 
cell cycle–regulated processes, we expect that the CDC28 genetic 
network is much larger than presented in this study. The finding 
that CDC28 genetically interacted with factors involved in HR 
was unexpected because Cdc28 has previously been shown to be 
required for HR (Aylon et al., 2004; Ira et al., 2004), and, there-
fore, one might have expected an epistatic relationship between 
Cdc28 and factors involved in HR. Our data indicate that although 
Cdc28 might have an important function in HR, it must also have 
that mitotic checkpoint functions are required for the forma-
tion of GCRs, possibly by preventing loss of damaged chro-
mosomes. We do not know the exact mechanism of suppression 
of GCR rates by the hypomorphic cdc28-as1 and cdc28-5M 
alleles, although we can exclude a role for the Cdc28 target 
Sae2 because deletion of SAE2 did not suppress the GCR rate 
of mre11 mutants. Although we found that Cdc28 activity by 
itself was not required for recovery from DNA replication arrest, 
it was essential when Mre11-dependent DSB repair mecha-
nisms were defective (Fig. 4). Therefore, one explanation for 
the suppression of GCRs is that Cdc28 has a redundant func-
tion in the repair of damaged chromosomes and cooperates 
with different DNA repair pathways to promote cell viability 
by repairing DSBs or by healing broken chromosomes in a 
GCR-prone manner. For instance, Cdc28 has been found to be 
required for HR (Ira et al., 2004), which is error free, but in the 
absence of HR, the cell deploys alternative chromosome heal-
ing pathways that can give rise to GCRs (for review see Kolodner 
et al., 2002). A major pathway involved in the formation of 
GCRs is de novo telomere addition (Pennaneach et al., 2006). 
Interestingly, Cdc28 has several functions in the processing of 
telomeres (Frank et al., 2006; Vodenicharov and Wellinger, 
2006;  Li  et  al.,  2009)  and  in  telomeric  recombination  in 
telomerase-deficient cells (Grandin and Charbonneau, 2003). 
Consequently, inhibiting Cdc28 activity could reduce the ac-
tivity of several of the major pathways that repair and heal dam-
aged chromosomes. The damaged chromosomes might then be 
lost during the next cell cycle, resulting in cell death and an appar-
ent suppression of GCR rates. A similar model has been pro-
posed previously to explain suppression of GCRs by mutations 
in mitotic checkpoint genes (Myung et al., 2004). Suppression   
of GCR rates through loss of damaged chromosomes resulting 
in cell death is supported by several of our other findings, in-
cluding (a) hypomorphic cdc28 alleles show strong growth 
defects  when  combined  with  mutations  like  mre11  and 
rad27, which are known to cause high levels of spontaneous 
DSBs and increased GCR rates, (b) cdc28-5M mre11 double 
mutants  have  increased  mitotic  catastrophe  after  treatment 
Table III.  Genetic interactions with CDC28 (Continued)
Relevant genotype Sensitivity to 200 nM 1-NM-PP1
  CDC28 cdc28-as1
Chromatin organization
asf1  +++
cac1  
Telomeres
pif1  
tlc1  ++++
Oxidative stress response
tsa1  
Cdc28 regulation
sic1  
,  not  more  sensitive/equally  sensitive  to  cdc28-as1;  +,  slightly  slower 
growth compared with cdc28-as1 single mutant; ++, slow growth compared 
with cdc28-as1 single mutant; +++, severely reduced growth compared with 
cdc28-as1 single mutant; ++++, near death or dead compared with cdc28-as1 
single mutant.JCB • VOLUME 185 • NUMBER 3 • 2009   434
(Hanahan and Weinberg, 2000), and the types of genome re-
arrangements that are seen in cancer parallel those of GCRs in 
S. cerevisiae (Putnam et al., 2005). Although a single Cdk (Cdc28/
Cdk1) controls the cell cycle in S. cerevisiae, in mammalian 
cells,  five  Cdks  related  to  Cdc28  (Cdk1,  Cdk2,  Cdk4,  and 
Cdk6) have been implicated in driving the cell cycle. Recent 
genetic evidence identified Cdk1 as the main player, and al-
though, under normal conditions, Cdk2, Cdk4, and Cdk6 may 
be more important for cycling of specialized cells, they appear to 
play a role in driving the cell cycle in tumor cells (Malumbres, 
2005;  Malumbres  and  Barbacid,  2005,  2009).  Interestingly,   
aberrant  Cdk  activity  induces  DNA  damage  in  mammalian 
cells and may contribute to genome rearrangements that are 
additional  functions  in  the  maintenance  of  genome  stability.   
Indeed, we found that Cdc28 may cooperate with Mre11 to pre-
vent  mitotic  catastrophe  after  DNA  damage  during  S  phase, 
which is in line with a previous study that showed that Cdc28 
prevents chromosome loss during mitosis (Kitazono and Kron, 
2002). Our finding that Cdc28 appears to be required for forma-
tion of GCRs supports the idea that it prevents loss of damaged 
chromosomes, although the mechanism and the relevant targets 
of Cdc28 in this process still need to be revealed.
Cdks and genome stability in cancer
Evasion of antigrowth signals to allow unrestricted entry into 
S phase is a characteristic of cancer, as is genome instability 
Figure 5.  CDC28 genetically interacts with pathways involved in maintenance of genome stability. (A) Synthetic lethal interaction between cdc28-5M and 
rad6. CDC28/cdc25-5M RAD6/rad6 diploids were sporulated, and tetrads were dissected. All combinations except the rad6 cdc28-5M double mutant 
were observed. (B) Expression of rad6-149 partially rescues the synthetic lethality of the cdc28-5M rad6 mutant. 10-fold dilutions of log-phase cell cultures 
were spotted on YPD plates and incubated until colonies were visible. (C) CDC28 genetic interaction map.435 CDC28 AND MAINTENANCE OF GENOME STABILITY • Enserink et al.
the TRP1 marker or part of plasmid YIplac204–7xARSH4 linked to TRP1, 
respectively. Both plasmids were provided by J.D. Diffley (Cancer Research 
UK London Research Institute, Hertfordshire, England, UK).
Sensitivity to chronic exposure to DNA-damaging agents and genetic 
interaction screen
10-fold dilutions of log-phase cell cultures were spotted on YPD supple-
mented with drugs, as indicated in the figures and figure legends, and incu-
bated at 30°C, and pictures were taken when colonies were visible. UV 
irradiation was performed using a UV cross-linker (model 2400; Stratalinker). 
Genetic interactions with cdc28-as1 were determined by spotting mutants 
on YPD or on YPD containing the indicated concentrations of 1-NM-PP1.
Cell survival after short treatments with drugs
Cells from log-phase cultures were arrested in 10 µg/ml  factor for 3 h 
and released into YPD for 30 min to allow cells to pass Start and enter 
S phase, which is a Cdc28-dependent event. As indicated, 10 µM 1-NM-PP1 
(experiments involving cdc28-as1 mutants) was added for 5 min before 
cells were treated with 200 mM HU, 0.05% MMS, or 0.1, 0.3, or 1 µg/ml 
phleomycin for 2 h, as indicated; alternatively, in experiments involving 
cdc28-5M, cells were incubated in a 42°C water bath for 5 min to rapidly 
inactivate Cdc28-5M before incubating at 37°C in the presence of drugs. 
Cells were then washed, plated on YPD plates, and incubated at 30°C until 
colonies appeared. Colonies were counted, and cell survival was calcu-
lated as the percentage of the colony-forming units of untreated WT cells. 
To determine cell survival of 1-NM-PP1–mediated cell cycle arrest, log-
phase cell cultures were arrested with 10 µM 1-NM-PP1 for 3 or 8 h before 
being washed and plated on YPD. Cell survival was then calculated as 
described above.
Determination of Ddc2 foci
Log-phase cells were arrested in 10 µg/ml  factor for 3 h and released 
into YPD supplemented with 15 µg/ml nocodazole (to prevent untreated 
cells from entering the next cell cycle) for 30 min to allow cells to enter   
S phase. 10 µM 1-NM-PP1 was then added for 5 min, and cells were either 
left untreated or treated with 1 µg/ml phleomycin for 2 h. Cells were 
transferred to ice until imaged. Ddc2-GFP foci in living cells were visual-
ized in YPD at RT with an inverted microscope (Eclipse TE300; Nikon) 
equipped with a 100× NA 1.40 Plan-Apochromat objective lens (Nikon), 
using a charge-coupled device camera (Orca-ER; Hamamatsu Photonics) 
and MetaMorph software (MDS Analytical Technologies). Images were 
processed using Photoshop (Adobe) and Illustrator (Adobe). At least 100 
cells were counted, and the number of cells with at least one Ddc2-GFP 
focus was calculated as the percentage of the total cell population of that 
specific sample.
GCR assays and fluctuation assays
GCR rates and fluctuation rates using the CAN1, lys2-Bgl, and the hom3-10 
assays were determined as described previously (Marsischky et al., 1996; 
Greene and Jinks-Robertson, 1997; Tishkoff et al., 1997; Tran et al., 1997; 
Umezu et al., 1998; Chen and Kolodner, 1999).
Bioinformatics
Identification of components of the CDC28 genetic network involved in 
the preservation of genome stability was performed as described previ-
ously (Huang and Kolodner, 2005), with some modifications. In brief, a 
Saccharomyces Genome Database search was conducted with a query 
set of genes that showed the strongest genetic interactions with CDC28 
(RAD53, MRE11, RAD50, RAD52, BUB2, BUB3, MAD2, CTF4, CTF18, 
CSM3, RAD6, RAD18, RAD5, ASF1, POL32, RAD27, and TLC1) followed 
by data sorting with Excel (Microsoft). This dataset was then filtered by 
discarding all genes having less than five genetic interactions in common 
with the set of query genes to remove false interactions. Predictions of   
genetic interactions that we already tested in our initial screen were   
discarded. Finally, the remaining genes were grouped according to gene 
ontology annotations, and those gene ontology groups that contained 
genes that tested negative in our initial screen for genetic interaction with 
CDC28 were discarded.
Western blotting
Cell pellets were resuspended in 20% TCA and disrupted by vortexing at 
4°C for 15 min in the presence of glass beads. Lysates were centrifuged, 
pellets were washed with 70% ethanol and resuspended in Laemmli sam-
ple buffer, and the pH was neutralized using Tris base. Lysates were boiled, 
centrifuged, and resolved on SDS-PAGE followed by Western blotting using 
HRP-coupled Flag antibodies (Sigma-Aldrich).
observed in cancer (Bartkova et al., 2005; Enders and Maude, 
2006; Malumbres and Barbacid, 2009). Indeed, overexpression 
of cyclin E leads to chromosomal instability in immortalized 
rat embryo fibroblasts and human breast epithelial cells (Spruck 
et al., 1999). Our data show that aberrant Cdk activity is not 
just sufficient but actually also required for formation of ge-
nome rearrangements. We also found that cells with reduced 
Cdk activity are greatly sensitized to DNA-damaging agents, 
and, furthermore, they depend heavily on pathways that are in-
volved in DNA repair such as the Me11 DSB repair pathway 
and the Rad6 pathway but also on intact M-phase checkpoints. 
Therefore, the efficacy of current cancer treatments based on  
irradiation, DNA damage–based chemotherapy, or paclitaxel-
based drugs that target microtubules might be improved by 
combining them with broad-range CKIs. Indeed, several on-
going clinical trials are focused on Cdks and involve combina-
tion therapies (Shapiro, 2006; Malumbres and Barbacid, 2009).
In conclusion, CDC28 functions in a genetic network that 
preserves genome integrity. It cooperates with the MRE11 path-
way in recovery from DNA replication arrest by preventing   
mitotic catastrophe during mitosis; however, Cdc28 is also re-
quired for the formation of GCRs. Therefore, Cdc28-mediated 
maintenance of cell viability during DNA damage may come at 
a cost: genome rearrangements.
Materials and methods
Yeast strains and plasmids
S. cerevisiae strains were grown in standard YPD medium. Strains were   
directly derived from the S288c strain RDKY3615 using either standard gene 
replacement methods or intercrossing (Table S2). To construct the cdc28-as1 
strain, the coding region of cdc28-as1 was amplified from pRS306–cdc28-
as1 (gift from K. Shokat, University of California, San Francisco, San Fran-
cisco, CA) and subcloned into pRS303 and pRS304. Subsequently, a PCR 
product spanning the coding sequences of cdc28-as1 and either HIS3 or 
TRP1 was used to transform RDK3615. Positive clones were identified by 
sensitivity to 1-NM-PP1. Sequencing revealed that two sites differed from the 
published sequence: A24C and T874C (resulting in Thr8Pro and Ile291Thr). 
These mutations did not affect sensitivity to 1-NM-PP1 (Fig. 1 and not de-
picted). To construct the cdc28-5M strain, a region spanning the coding 
sequences  of  cdc28-5M  and  TRP1  was  PCR  amplified  from  pRS304–
cdc28-5M (gift from M. Cai, National University of Singapore, Singapore) 
and then used to transform RDK3615 to Trp
+. Plasmids pRDK1293 and 
pRDK1294 were constructed by inserting a PCR product containing the 
nourseothricin resistance marker NAT-NT1 into the BamHI site of yCP50-
derived plasmids harboring RAD6 and rad6-149, respectively, which were 
provided by M.A. Osley (University of New Mexico, Albuquerque, NM). 
To construct strains RDK6307 and RDK6308, the SIT1 ORF was replaced 
with a PCR product spanning either part of plasmid YIplac204, including 
Table IV.  GCR rates in mutants with seven copies of ARSH4
Strain Relevant genotype GCR rates (×10
10)
RDK3615 WT 3.5 (1)
a
RDK6307 sit1::control DNA <4.0 (1)
b
RDK6308 sit1::7xARSH4 13.9 (4)
RDK6311 mre11 sit1::control DNA 2,963 (847)
RDK6312 mre11 sit1::7xARSH4 12,539 (3,580)
Numbers in parentheses indicate fold increase over WT. The GCR rates are 
shown as events per generation.
aData from Chen and Kolodner (1999).
bGCR rate could not be accurately calculated because GCRs were not detected 
in a large enough proportion of the cultures.JCB • VOLUME 185 • NUMBER 3 • 2009   436
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FACS analysis
Cells were fixed in 70% ethanol for 1 h at RT, harvested by centrifugation, and 
resuspended in 50 mM sodium citrate buffer, pH 7.0. Cells were sonicated 
(three pulses of 1 s each), centrifuged, resuspended in sodium citrate buffer 
containing 250 µg/ml RNase A and 1 mg/ml proteinase K, and incubated 
overnight at 37°C. The cells were then harvested by centrifugation, resus-
pended in 1 ml of sodium citrate buffer containing 1 µM Sytox green (Invitro-
gen), and incubated at RT for at least 1 h before being analyzed by FACS.
PFGE
Overnight cultures of the indicated strains were diluted in fresh YPD and 
allowed to resume growth at 30°C to reach 10
7 cells/ml (hemocytometer 
readings). 10 ml from each culture was centrifuged, and cells were fixed 
with 70% ethanol for at least 1 h at RT. The remaining culture of each strain 
was synchronized by the addition of HU (Sigma-Aldrich) to a final concen-
tration of 0.2 M. After incubation at 30°C for 2 h, the majority of the cells 
(>90%) was arrested in S phase with large buds. Aliquots were taken and 
fixed in 70% ethanol. The remaining culture was washed to remove HU 
and  resuspended  in  fresh  YPD  containing  10  µg/ml    factor  (Sigma-
  Aldrich). After incubation at 30°C (or 37°C as indicated) for 3 h, samples 
were collected, and cells were fixed in 70% ethanol as above. Preparation 
of agarose-embedded yeast DNA was performed with contour-clamped 
homogeneous electric field (CHEF) genomic DNA plug kit (Bio-Rad Labora-
tories) according to the manufacturer’s instructions. 6 × 10
7 fixed cells 
were washed and set into each agarose plug. All plugs were subsequently 
treated with lyticase and proteinase K before loading onto an agarose 
separation gel (1% Megabase agarose; Bio-Rad Laboratories). PFGE was 
run in CHEF Mapper equipment (Bio-Rad Laboratories) in 0.5× Tris-borate-
EDTA buffer at 14°C with an angle of 120°, a voltage gradient of 6 V/cm, 
and switch times of 60 s for 15 h and 90 s for 7 h. The gel was stained 
with ethidium bromide before being photographed. The relative amount of 
DNA fragmentation was determined as follows. Part of the fragmented 
DNA of subchromosomal size (Fig. S2) was quantified using the histogram 
tool of Photoshop and corrected for background noise. This was then nor-
malized against the amount of DNA of chromosome XI (quantified and cor-
rected in the same way). The mean and standard error of the mean were 
then calculated using data from three independent experiments. Only treat-
ments at 30°C were analyzed because incubation at 37°C did not further 
increase chromosome fragmentation.
Online supplemental material
Fig. S1 shows that Cdc28 functions in the DNA damage response but is not 
important for survival of acute DNA damage. Fig. S2 shows an example of 
a PFGE gel. Fig. S3 quantifies the genetic interactions of several genes with 
CDC28. Table S1 displays the predicted as well as confirmed genetic inter-
actions with CDC28 using a bioinformatics approach. Table S2 shows the 
yeast strains used in this study. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200811083/DC1.
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